The U.S. Food and Drug Administration (FDA) on Monday extended its review timeline for REGENXBIO Inc.’s Biologics License Application (BLA) for clemidsogene lanparvovec (RGX-121) for Mucopolysaccharidosis II (MPS II), also known as Hunter syndrome. The Prescription Drug User Fee Act (PDUFA) goal date has been extended from November 9, 2025, to February 8, 2026. The extension follows the company’s submission...

BRASILIA, Aug 19 (Reuters) - Banco do Brasil said on Tuesday it is prepared to deal with complex, sensitive issues involving global regulations after a top court justice ruled foreign laws cannot be automatically applied in Brazil. The statement followed a Reuters query about the U.S. Magnitsky Act, which President Donald Trump used last month to sanction Supreme Court Justice...

WASHINGTON (Reuters) -U.S. soybean farmers urged President Donald Trump in a Tuesday letter to reach a trade deal with China that secures significant soybean purchase agreements, warning of dire long-term economic outcomes if the country continues to shun the U.S. crop.  China, the world's largest soybean buyer, is turning to Brazilian cargoes amid trade tensions with the U.S. and ongoing negotiations....

NEW YORK (Reuters) -Mergers and acquisitions in the U.S. oil and gas sector tripled last year despite softer commodity prices as energy companies boosted spending to improve efficiency and profits, according to a report released on Tuesday. WHY IT'S IMPORTANT The jump in dealmaking marks a shift in strategy after years of focusing on shareholder returns over growth as commodity...